Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Aram Akopyan, MD, LAc
Dr. Aram A. Akopyan, a licensed acupuncturist in California, holds advanced degrees in computer science, information technology and TCM. He completed his clinical residency at the Sichuan Academy of TCM in China and subsequently earned his qualifications for medical doctor (MD), specializing in physical medicine and rehabilitation. He serves as the clinical director for Nepal Pain Relief; and is the director of communications for the European Traditional Chinese Medicine Association (ETCMA). As chair of the Artificial Intelligence (AI) Task Force for the NCCAOM, Dr. Akopyan spearheads initiatives to incorporate artificial intelligence into acupuncture for enhanced patient care.